Archived App (Last seen on 9 Mar 2026)
This is an archived listing of the app previously available on the App Store.
Participate in a COVID-19 immunity study by tracking your exposure, symptoms, and health data. Your anonymized information will aid the scientific community in developing better policy and treatment decisions.
1.5
June 18, 2020
Additional language and stability enhancements
Obvio-19 is used by US participants to contribute anonymized data to a pioneering research study monitoring COVID-19 exposure, symptoms, risk factors, and immune response. This data helps the scientific and medical community make informed policy, prevention, and treatment decisions.
According to the app description, everyone is eligible to participate in the Obvio-19 study. The enrollment process is described as easy.
Obvio-19 tracks and records exposure, symptoms, medications, health history, medical visits, and tests through self-reported data from participants.
Yes, Obvio-19 is available for free. There are no in-app purchases or advertisements mentioned in the provided data.
Obvio-19 is supported on iPhone, iPad, and iPod devices. It is designed for Apple's mobile operating system.
The latest version of Obvio-19 is 1.5, which was last updated on June 18, 2020. The initial release date was April 22, 2020.
Obvio-19 has an age rating of 17+. This indicates that the content may be suitable for individuals aged 17 and older.
Obvio-19 has a rating of 3.2 stars based on 6 ratings. This suggests a mixed to slightly positive user reception.
